Subscribe
Healthcare

Trump’s drug-price crackdown misses the mark, experts say

By Robert King
Published
Add Washington Examiner on Google
Trump’s drug-price crackdown misses the mark, experts say

Less than a month into his new job, Alex Azar got some praise from his new boss, President Trump.

The newly minted head of the Department of Health and Human Services had already done a great job lowering drug prices, according to Trump.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Alex Azar Department of Health and Human Services Donald Trump FDA Henry Waxman Insurance Industry Medicare and Medicaid Patent Law Pharmaceutical Industry Robert King Ron Wyden Senate